# Rosuvastatin ORBITAL Germany

> **NCT00379249** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 8000 (—)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT00379249
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-02
- **Primary completion:** —
- **Final completion:** 2004-02
- **Target enrollment:** 8000 (—)
- **Last updated:** 2009-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00379249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00379249, "Rosuvastatin ORBITAL Germany". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00379249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*